| Autor: |
Napolitano, Filomena, Terracciano, Chiara, Bruno, Giorgia, Nesti, Claudia, Barillari, Maria R., Barillari, Umberto, Santorelli, Filippo M., Melone, Mariarosa A.B., Esposito, Teresa, Sampaolo, Simone |
| Zdroj: |
American Journal of Medical Genetics. Part A; Jan2020, Vol. 182 Issue 1, p176-182, 7p |
| Abstrakt: |
Dominant Optic Atrophy and Deafness (DOAD) may be associated with one or more of the following disorders such as myopathy, progressive external ophthalmoplegia, peripheral neuropathy, and cerebellar atrophy ("DOA‐plus"). Intra‐ and interfamilial variability of the "DOA‐plus" phenotype is frequently observed in the majority of the patients carrying the same mutation in the OPA1 gene. We are describing two familial cases of "DOA‐plus" carrying the same c.1334G>A (p.Arg445His) mutation in OPA1 and disclosing different clinical, pathological and biochemical features. The two patients showed different expression levels of the mitochondrial OMI/HTRA2 molecule, which acts as a mitochondrial stress sensor and has been described to interplay with OPA1 in in vitro studies. Our data offer the cue to inquire the role of OMI/HTRA2 as a modifier gene in determining the "DOAplus" phenotype variability. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text